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Abstract
Hhex is required for early development of the liver. A null mutation of Hhex results in a failure to form the liver bud and embryonic lethality.
Therefore, Hhex null mice are not informative as to whether this gene is required during later stages of hepatobiliary morphogenesis. To address
this question, we derived Hhex conditional null mice using the Cre-loxP system and two different Cre transgenics (Foxa3-Cre and Alfp-Cre).
Deletion of Hhex in the hepatic diverticulum (Foxa3-Cre;Hhexd2,3/−) led to embryonic lethality and resulted in a small and cystic liver with loss of
Hnf4α and Hnf6 expression in early hepatoblasts. In addition, the gall bladder was absent and the extrahepatic bile duct could not be identified.
Loss of Hhex in the embryonic liver (Alfp-Cre;Hhexd2,3/−) caused irregular development of intrahepatic bile ducts and an absence of Hnf1β in
many (cystic) biliary epithelial cells, which resulted in a slow, progressive form of polycystic liver disease in adult mice. Thus, we have shown that
Hhex is required during multiple stages of hepatobiliary development. The altered expression of Hnf4α, Hnf6 and Hnf1β in Hhex conditional null
mice suggests that Hhex is an essential component of the genetic networks regulating hepatoblast differentiation and intrahepatic bile duct
morphogenesis.
© 2007 Elsevier Inc. All rights reserved.Keywords: Hhex; Liver; Biliary tract; Extrahepatic bile duct; Polycystic liver diseaseIntroduction
The liver and biliary tract arise from the hepatic diverticu-
lum, which develops as an out-pocketing of the ventral foregut
endoderm around embryonic day 9.5 (E9.5) in mice (reviewed
in Lemaigre and Zaret, 2004). For the most part, the cranial
portion of the hepatic diverticulum gives rise to the liver and
intrahepatic biliary tree while the caudal portion forms the
extrahepatic biliary tract (Du Bois, 1963; Shiojiri, 1979). Early
hepatoblasts in the diverticulum migrate into the surrounding
mesenchyme and form the liver bud and cystic primordium (gall
bladder precursor) by E10.5. Bipotential hepatoblasts within the
liver bud eventually give rise to hepatocytes and biliary
epithelial cells (BEC), which line the bile ducts (Shiojiri,
1979; reviewed in Shiojiri, 1997). BEC of the intrahepatic bile⁎ Corresponding author. Fax: +1 203 785 5833.
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doi:10.1016/j.ydbio.2007.05.028ducts (IHBD) originate from hepatoblasts surrounding branches
of the portal vein within the embryonic liver (Shiojiri, 1979,
1984). Development of IHBD occurs through a series of distinct
stages including differentiation of BEC around E13.5, forma-
tion of the ductal plate by E15.5, and ductal plate remodeling
that ends shortly after birth (Clotman et al., 2002). The ducts of
the extrahepatic biliary tract are also lined by BEC, although
development of the intrahepatic and extrahepatic biliary
systems occurs separately and apparently through different
mechanisms. The extrahepatic biliary system forms by budding
from the hepatic diverticulum in close association with the liver
bud and is composed of the gall bladder and several relatively
large ducts, which converge to form the extrahepatic bile duct
(EHBD) that connects the liver to the duodenum (Du Bois,
1963; Shiojiri, 1979).
The homeobox gene Hhex is expressed in the ventral foregut
endoderm at E8.5 (Thomas et al., 1998; Bogue et al., 2000) and
is required for very early development of the liver (Hallaq et al.,
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Hhex−/− mouse embryos, the hepatic diverticulum is specified
in the foregut endoderm, but proliferation of cells in the
diverticulum is reduced (Bort et al., 2004) and subsequent
migration of early hepatoblasts into the surrounding mesench-
yme fails to occur (Bort et al., 2006). As a result, the liver bud is
absent in Hhex null embryos (Keng et al., 2000; Martinez-
Barbera et al., 2000). In addition, Hhex mutants are lacking the
cystic primordium, which has been attributed to defective
movements within the foregut endoderm (Bort et al., 2004).
Therefore, Hhex is essential for the delamination and migration
of early hepatoblasts from the hepatic diverticulum in formation
of the liver bud and in the absence of Hhex hepatic development
is arrested, after the specification stage, at E9.5.
The expression pattern of Hhex has also been described in
hepatobiliary tissue during later stages of development. Hhex
mRNA has been detected in the liver bud, the embryonic liver,
the gall bladder and the extrahepatic bile duct (Thomas et al.,
1998; Bogue et al., 2000). Furthermore, Hhex is expressed in
the adult liver in hepatocytes and IHBD cells (Bogue et al.,
2000; Keng et al., 1998), and Hhex has been shown to regulate
the in-vitro expression of the ntcp gene (Denson et al., 2000),
which encodes a bile acid transporter expressed in adult
hepatocytes. These findings suggest that Hhex has important
roles during later stages of hepatobiliary morphogenesis, which
thus far have not been addressed using genetic means because
of the very early arrest in liver and biliary tract development in
Hhex−/− embryos.
In this study, we have developed a Hhex conditional null
allele using the Cre-loxP system to determine the function of
Hhex during later stages of liver and biliary tract development.
We employed the Foxa3-Cre (Lee et al., 2005a, 2005b) and
Alfp-Cre (Parviz et al., 2003) transgenes to eliminate Hhex in
the hepatic endoderm at different developmental stages.
Elimination of Hhex in the hepatic diverticulum (Foxa3-Cre;
Hhexd2,3/−) resulted in a severely hypoplastic and cystic liver,
with major defects in development of the extrahepatic biliary
tract. The liver-enriched transcription factors (LETFs) HNF4α
and HNF6 were absent in hepatoblasts of Foxa3-Cre;Hhexd2,3/−
embryos at E13.5, which resulted in major defects in hepatic
epithelial development. Deletion of Hhex in the embryonic liver
(Alfp-Cre;Hhexd2,3/−) caused abnormal morphogenesis of
IHBD, with a down-regulation of Hnf1β in many biliary
epithelial cells, and polycystic liver disease in adult mutant
mice. Our results show that Hhex is required in hepatobiliary
development after liver bud formation, and that Hhex is
essential for proper hepatoblast differentiation and bile duct
development.
Materials and methods
Derivation of Hhexneoflox and Hhexflox alleles
To construct the targeting vector, a Hhex P1 genomic clone was isolated
(Bogue et al., 2003). A loxP element was inserted in between XbaI and SpeI
sites of the 3rd intron of a Hhex 3′ genomic fragment. An XhoI–BsaI 3′ Hhex
fragment containing this loxP site insertion was blunt-end ligated into a BglII
site in plasmid GR88 (from Trevor Williams, University of Colorado HealthSciences Center). This plasmid contained a loxP site upstream of a neomycin
resistance cassette flanked by FRT sites. Finally, a 3.8-kb 5′ Hhex SnaBI–XhoI
fragment was blunt-end ligated onto the above 3′ construct. The final targeting
vector was sequenced in its entirety and used for the generation of Hhexneoflox
ES cell clones by the Animal Genomics Services at the Yale School of Medicine
according to standard procedures (Nagy et al., 2002). Mice used in this study
were maintained on mixed backgrounds (129S1/Sv and C57Bl/6).
The Flp transgenic mouse (Rodriguez et al., 2000) was provided by the
Animal Genomics Services at the Yale School of Medicine. The Hhexflox allele
was cloned and sequenced to verify that the recombination event had occurred as
designed.
Generation of Hhex conditional null mice
To derive our Hhex conditional null mice, Alfp-Cre (Parviz et al., 2003) and
Foxa3-Cre (Lee et al., 2005a, 2005b) mice were bred onto our Hhex+/−
background (Bogue et al., 2003). For almost all crosses, Cre;Hhex+/− mice were
bred to our Hhexflox/+ or Hhexflox/flox mice. Embryos were staged according to
Kaufman (1992). Hhex+/− and Hhexflox/− littermates were used as controls in
comparison to Hhex conditional null mutants.
Histology and Immunohistochemistry
Embryos and adult liver tissue were processed for frozen and paraffin
sectioning according to standard procedures (Nagy et al., 2002). The antibodies
used were as follows; rabbit anti-Hhex (Ghosh et al., 2000), rabbit anti-
cytokeratin (DakoCytomation #Z0622), goat anti-HNF4α (Santa Cruz Bio-
technology #SC-6556), rabbit anti-HNF6 (Santa Cruz Biotechnology #SC-
13050), and goat anti-HNF1β (Santa Cruz Biotechnology #SC7411).
Immunohistochemistry on sections was performed using Antigen Unmasking
Solution (H-3300; Vector Labs), Avidin/Biotin Blocking kit (SP-2001; Vector
Labs), Vectastain ABC kit (PK-6100; Vector Labs), and the DAB peroxidase
substrate kit (SK-4100; Vector Labs) according to the manufacturer's protocols.
For picro-sirius red staining, paraffin sections were cleared in xylene, rehydrated
through an ethanol series, and rinsed in water. Slides were then placed in picro-
sirius red solution (0.5 g Sirius red F3B in 500 ml saturated aqueous picric acid;
Sigma), for 1 h at RT. Finally slides were washed twice in acetic acid water (5 ml
glacial acetic acid in 11 ml distilled water), then dehydrated and cleared in
xylene for mounting.
Immunofluorescence and imaging
Immunofluorescence was performed according to standard procedures using
Retrieve-All 2 (Signet Laboratories), Alexa Fluor 594 donkey anti-goat, Alexa
Fluor 594 goat anti-rabbit, Alexa Fluor 488 goat anti-mouse, and Alexa Fluor
488 donkey anti-rabbit (Molecular Probes), Hoechst 33342 (Molecular Probes),
and the Prolong Antifade kit (P-7481, Molecular Probes) according to the
manufacturer's recommendations. Antibodies used were as follows; anti-Ki-67
antibody (BD Pharmingen, #556003), anti-human cytokeratin (DakoCytoma-
tion #A0575), and anti-HNF4α (Santa Cruz #SC-6556). All fluorescent images
were captured on a Zeiss Axiovert 200 M with an Axiocam MRm camera using
Axiovision software and the ApoTome mode. Images are a ‘3-D’ representation
of optical sections through approximately 3.5 microns of tissue.
Results
Hhex is expressed in hepatobiliary tissue throughout
development
We have previously detected Hhex mRNA in BEC of the
extrahepatic and intrahepatic biliary tract during embryogenesis
and in the adult liver (Bogue et al., 2000). To extend these
results, we analyzed Hhex expression in the liver and biliary
tract by immunohistochemistry using a polyclonal anti-Hhex
antibody (Ghosh et al., 2000). At E10.5, Hhex is detected in
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extrahepatic biliary tract precursors including the gall bladder
primordia (Figs. 1A, B). At E15.5 Hhex was highly expressed in
the extrahepatic bile duct (EHBD) epithelium (Fig. 1C) and in
biliary cells of the ductal plate surrounding large branches of
the portal vein near the liver hilum (Fig. 1D). Hhex was also
detected in hepatocytes and biliary cells of the IHBD during
late embryogenesis (Fig. 1E) and in the adult liver (Fig. 1F).
Therefore, Hhex is expressed in the liver and biliary
epithelium from the onset of hepatobiliary morphogenesis
and into adulthood.
Derivation of a Hhex conditional null allele
To elucidate the role of Hhex in later stages of hepatobiliary
development, we constructed a targeting vector to generate a
Hhex conditional null allele using the Cre-loxP system (see
Supplementary Fig. 1A). This construct was used to generate a
targeted ES cell clone from which three chimeric founderFig. 1. Hhex immunostaining reveals expression in the liver and biliary
epithelium throughout embryogenesis and in the adult. (A) E10.5 Hhex
expression in the liver bud (lb), the extrahepatic bile duct precursor (ehbd), and
the cystic duct precursor (cd). (B) Hhex is detected in the gall bladder
primordium (gb) at E10.5. (C) Hhex expression in the EHBD (outlined) at
E15.5. (D) Hhex is also expressed in the biliary cells of the ductal plate
(arrowheads) near the liver hilum. (E) Hhex is present in hepatocytes
(arrowhead), intrahepatic bile duct cells (arrow), and endothelial cells (double
arrowhead) at E18.5. (F) In the adult liver, Hhex is detected in hepatocytes
(arrowhead) and biliary cells (arrow). ihbd= intrahepatic bile duct, d=duode-
num, p=pancreas, pv=portal vein.males were obtained. Founder males were backcrossed to
C57Bl/6 mice to derive the F1 generation of Hhexneoflox/+
mice. Genotyping of the Hhexneoflox/+ mice was performed by
Southern and PCR (Supplementary Fig. 1B). Hhexneoflox/+ F1
mice were then used to derive the Hhex conditional allele
(Hhexflox) after crossing to Flp/Flp transgenics (Rodriguez et
al., 2000). This generated Flp;Hhexflox/+ F1 mice, which were
then backcrossed one additional generation to C57Bl/6. These
Hhexflox/+ F2 mice and their progeny were used for all further
analysis, and genotyping was verified by Southern and PCR
(Supplementary Fig. 1C). To confirm that the Hhexflox allele
was functionally equivalent to the wild-type allele we
intercrossed Hhexflox/+ mice. Hhexflox/flox pups were born at a
normal Mendalian ratio and were healthy and fertile,
indicating that the Hhexflox allele was functionally wild-type.
Finally, we used PCR and sequencing to confirm the presence
of the Hhexd2,3 allele in our Hhex conditional null mice after
crossing the Hhexflox allele to Alfp-Cre mice (Supplementary
Fig. 1D).
Hhex is essential for proper morphogenesis of the extrahepatic
biliary tract
To test whether Hhex plays a role in the development of the
extrahepatic biliary tract, we derived mutants in which Hhex
was deleted in the hepatic diverticulum by crossing Hhexflox
mice with the Foxa3-Cre transgene (Lee et al., 2005a)
backcrossed to our Hhex+/− mice (Hallaq et al., 2004). Foxa3-
Cre has been shown to be active at E8.5 in ventral foregut
endoderm, including the cells of the hepatic diverticulum (Lee
et al., 2005a, 2005b). Thus, Foxa3-Cre;Hhexd2,3/− (conditional
null) mice should lack Hhex both in the liver bud and
extrahepatic biliary tract primordia.
In Foxa3-Cre;Hhexd2,3/− embryos at E10.5, Hhex was
absent in almost all endoderm-derived cells of the liver bud
and extrahepatic biliary tract primordia (compare Fig. 2A with
Fig. 2B). Expression of Hhex was unaffected in endothelial
cells within the Foxa3-Cre;Hhexd2,3/− liver confirming the
deletion was specific to endoderm-derived cells (Fig. 2B).
Therefore, Hhex was efficiently deleted in hepatobiliary tissue
of mutant embryos by E10.5.
Development of the extrahepatic biliary tract was severely
perturbed in Foxa3-Cre;Hhexd2,3/− embryos. The liver-
enriched transcription factor HNF6 is normally detected in
cells of the developing liver and in extrahepatic biliary tract
precursors (Clotman et al., 2002; Pierreux et al., 2004). In
control embryos at E10.5, HNF6 was expressed in the liver
bud and gall bladder primordium (Fig. 2C) as previously
described. However, the gall bladder primordium could not
be identified in Foxa3-Cre;Hhexd2,3/− embryos (Fig. 2D). In
addition, few cells were HNF6 positive in the liver bud of
mutant animals at this stage. At E13.5, the Foxa3-Cre;
Hhexd2,3/− mutant liver was hypoplastic compared to the
control (compare Fig. 2E with Fig. 2F). Cytokeratin (CK)
immunostaining revealed that development of the EHBD was
also abnormal in Foxa3-Cre;Hhexd2,3/− embryos. At E13.5 in
controls, the EHBD forms just caudal to the liver and ventral
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layer of columnar to cuboidal epithelial cells (Fig. 2I). In
contrast, the EHBD appeared to be absent in Foxa3-Cre;
Hhexd2,3/− embryos (Fig. 2H), and the normal EHBD
epithelium was replaced by pseudostratified epithelium
resembling the duodenum (Fig. 2J). We verified that Hhex
was absent in the abnormal, duct-like structure in the mutant by
Hhex immunostaining (Figs. 2K, L).Next we examined Foxa3-Cre;Hhexd2,3/− embryos at E16.5
to see how the EHBD phenotype progressed. At E16.5, the
EHBD forms a prominent duct that passes ventrolaterally from
the liver hilum to the duodenum adjacent to the portal vein and
pancreas, and is lined by a single cell layer of columnar
epithelium (Figs. 3A, C). In Foxa3-Cre;Hhexd2,3/− embryos,
duodenal-like mucosa extended directly from the duodenum to
the liver hilum (Figs. 3B, D). In addition, at the liver hilum,
there appeared to be dilated hepatic ducts and biliary cysts lined
by cuboidal epithelium (Fig. 3B). To confirm that this ectopic
tissue was indeed duodenal epithelium, we performed HNF4α
immunostaining. Hnf4α is expressed in the small intestine
(Drewes et al., 1996), but not in BEC (Clotman et al., 2005). In
control embryos, HNF4α was strongly expressed in the nucleus
of epithelial cells lining the duodenum (Figs. 3E, G), with a
very low level of expression in the epithelium lining the
EHBD (Fig. 3G). In Foxa3-Cre;Hhexd2,3/− embryos, HNF4α
was strongly expressed in the ectopic duodenal-like epithelial
cells (Fig. 3F), with expression localized to the nucleus in
these cells up to the liver hilum (Fig. 3H). This result
indicated that ectopic duodenal tissue apparently replaced the
EHBD in Foxa3-Cre;Hhexd2,3/− mutants.
In Foxa3-Cre;Hhexd2,3/− embryos, single cell layer colum-
nar/cuboidal epithelia was detected where the duodenum fused
to the liver, suggesting the presence of biliary epithelia.
Therefore, we examined the expression of HNF6, which is
expressed in biliary epithelia but not duodenal epithelia (Fig. 3I).
In Foxa3-Cre;Hhexd2,3/− embryos, almost all of the ectopic
duodenal tissue did not express HNF6, but some epithelial cells
near the base of the liver were positive for HNF6 (Fig. 3J). These
HNF6-positive cells most likely represent either hepatic duct
epithelium or a remnant of the EHBD. We conclude that inFig. 2. Deletion of Hhex in the hepatic diverticulum in Foxa3-Cre;Hhexd2,3/−
mutant embryos results in severe abnormalities in early development of the
extrahepatic biliary tract. (A, B) Hhex immunostaining at E10.5. (A) In the
control, Hhex is detected in the liver bud (outlined in solid line) and extrahepatic
biliary tract primordia (outlined in dashed line). The arrow marks the EHBD
precursor epithelium and the asterisk labels the gall bladder primordium. (B) In
the mutant, Hhex is efficiently deleted in the liver bud (outlined in solid line) and
in the presumptive EHBD precursor (outlined in dashed lines). The arrow marks
Hhex-negative cells in the EHBD precursor epithelium. The arrowhead labels an
endothelial cell. (C, D) HNF6 immunostaining at E10.5. (C) HNF6 is normally
expressed in the liver bud (lb) and gall bladder primordium (gb). (D) In the
mutant, the gall bladder primordium is absent. (E, F) Hematoxylin and eosin
(H&E) staining at E13.5. (E) Control liver. (F) The Foxa3-Cre;Hhexd2,3/−
mutant liver is hypoplastic compared to the control. (G–J) CK immunostaining
at E13.5. (G) In the control, the EHBD (boxed region) is a duct extending
ventro-caudal from the liver to the duodenum and ventral to the main portal vein
(pv). (H) In mutants, the EHBD could not be identified, and in its place were
duct-like structures with abnormal epithelium. (I, J) Higher magnification of the
boxed regions in E and F respectively. (I) Single cell layer cuboidal epithelium
(arrowhead) lines the EHBD (outlined) in the control. (J) In Foxa3-Cre;
Hhexd2,3/− embryos, abnormal duct-like structures (outlined) were mostly
lined by a pseudostratified epithelium (arrowheads), similar to the duodenum
(arrow). (K, L) Hhex immunostaining at E13.5. (K) Hhex is expressed in the
EHBD epithelium in the control (arrowhead). (L) Hhex is absent from the
abnormal duct-like structure, where the EHBD would normally form, in the
mutant (arrowhead). Ventral is to the left and all sections are sagittal.
mg=midgut, dv=ductus venosus, ht=heart.
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completely replaced by duodenum.
Hhex is required for normal hepatoblast differentiation
Deletion of Hhex in the hepatic diverticulum was embryonic
lethal and resulted in a severely hypoplastic liver in all Foxa3-
Cre;Hhexd2,3/− mutants analyzed. We examined expression of
Hnf4α (Figs. 4A–D), which is a marker for the hepatoblast in
the early embryonic liver and is required for normal
differentiation of hepatocytes (Parviz et al., 2003; Battle et al.,
2006). In control embryos at E13.5, HNF4α was detected in
hepatoblasts as expected (Figs. 4A, C). However, in Foxa3-
Cre;Hhexd2,3/− embryos, HNF4α was absent from almost all
hepatic cells (Figs. 4B, D). A similar result was seen for the
Onecut transcription factor HNF6 (Figs. 4E–H), which isrequired for proper hepatoblast differentiation and bile duct
development (Clotman et al., 2002). Interestingly, by E16.5
HNF4α and HNF6 were detected in many parenchymal cells
in the liver of Foxa3-Cre;Hhexd2,3/− embryos, although a
large number of hepatic cells were still negative (data not
shown). These results suggest that Hhex is required for the
expression of Hnf4α and Hnf6 only during the early stages of
hepatogenesis, and that loss of expression of these LETF's in
early hepatoblasts of Foxa3-Cre;Hhexd2,3/− mutants may lead
to a disruption of normal hepatic architecture later in
development.
By E16.5–E18.5, Foxa3-Cre;Hhexd2,3/− livers were grossly
abnormal compared to controls. At E16.5, in the mutant, tissue
at the ventral liver periphery had lost its cohesive structure and
this resulted in a trapping or pooling of blood cells in this region
(compare Fig. 5Awith Fig. 5B). At E18.5, normal hepatic tissue
morphology is characterized by numerous portal vein branches
associated with IHBD (Fig. 5C). However, in severely affected
mutants, normal hepatic architecture was disrupted and mutant
livers were extremely cystic with large dilated duct-like
structures and many smaller cysts (Fig. 5D). We examined
these duct-like structures and cysts in greater detail to determine
their cellular origin. In controls, immunostaining with a biliary-
specific CK antibody showed that only BEC were strongly
positive for CK (Fig. 5E). In Foxa3-Cre;Hhexd2,3/− mutant
embryos, many duct-like structures/cysts stained positive for
biliary CK (Fig. 5F). The larger CK-positive duct-like structures
probably represent dilated hepatic ducts, and other structures
most likely represent dilated IHBD or biliary cysts. However,
some duct-like structures/cysts had a heterogeneous epitheliumFig. 3. The EHBD was replaced by duodenum in Foxa3-Cre;Hhexd2,3/−
embryos at E16.5. (A–D) CK immunostaining. (A, B) Transverse sections near
the liver hilum. (A) In the control, the arrow marks the cuboidal epithelium of
the EHBD (outlined), and the arrowhead shows the large, broad villi of mucosa
in the duodenum. (B) In Foxa3-Cre;Hhexd2,3/− mutants, duodenal-like
epithelium is present at the liver hilum (arrowhead) and directly connects the
duodenum to the liver (outlined). Double arrowhead indicates a presumptive
dilated hepatic duct, and the arrow marks a biliary cyst within the liver. (C, D)
Sagittal section planes near the hilum. (C) In the control, the arrow indicates the
single-cell layer epithelium lining the EHBD (outlined). (D) In the mutant,
outlines show the presumptive position of the EHBD, which contains mostly
pseudostratified columnar epithelial cells with some single cell layer cuboidal
epithelium where the duodenum is connected to the liver (arrowhead). (E–H)
HNF4α immunostaining. (E) HNF4α is highly expressed in duodenal
epithelium, but is essentially absent in the EHBD (outlined). (F) Abnormal,
duodenal-like epithelium (HNF4α positive) is outlined in the Foxa3-Cre;
Hhexd2,3/− embryo, and it extends from the duodenum up to the liver hilum.
Arrowhead shows a dilated biliary duct within the liver. Arrow marks an
abnormal duct within the liver with a pseudostratified epithelium that is positive
for HNF4α. (G) In the control, strong nuclear HNF4α expression is detected in
duodenal epithelium (arrow), and very weak expression is detected in the EHBD
(arrowhead). (H) In theHhex conditional null embryo, strong nuclear expression
of HNF4α is detected up to the hilum (arrow), and the arrowhead shows weaker
expression in abnormal epithelium within the liver. (I) HNF6 is normally
expressed in the EHBD epithelium (arrowhead), but not in the duodenum. (J) In
mutants, HNF6 is absent in the ectopic duodenal tissue (arrow), but is detected
in some epithelial cells at the base of the liver (arrowhead). These cells probably
represent hepatic duct epithelia or a remnant of the EHBD. Ventral is to the left.
e=esophagus.
Fig. 4. Deletion of Hhex in the hepatic diverticulum resulted in an early loss of
HNF4α and HNF6 expression in the Foxa3-Cre;Hhexd2,3/− mutant liver. (A–D)
HNF4α immunostaining at E13.5. (A) HNF4α expression in hepatoblasts of the
control liver (liv). (B) HNF4α is absent in cells of the Foxa3-Cre;Hhexd2,3/−
mutant liver. (C, D) Higher magnifications of control and mutant livers,
respectively. (E–H) HNF6 immunostaining at E13.5. (E) HNF6 is expressed in
hepatoblasts of the control liver. (F) In the Foxa3-Cre;Hhexd2,3/− mutant,
HNF6 is absent in almost all hepatic cells. d/st=rostral duodenum/caudal
stomach. (G, H) Higher magnifications of control andmutant livers, respectively.
Ventral is to the left in panels A, B, E and F.
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cysts were composed entirely of cells that were CK negative. To
confirm that the heterogeneous cystic epithelium in mutants was
not due to incomplete deletion of Hhex in these cells, we
performed Hhex immunostaining at E18.5 (Figs. 5G, H). In
Foxa3-Cre;Hhexd2,3/− mutants, Hhex was absent in parenchy-
mal cells and cystic epithelial cells in the liver. HNF1β is a
LETF expressed in biliary epithelia (Fig. 5I) and required in
IHBD morphogenesis (Coffinier et al., 2002). However, in
Foxa3-Cre;Hhexd2,3/− mutants, HNF1β was absent in many
cystic biliary epithelial cells (Fig. 5J). Dual immunolabeling for
CK and HNF4α confirmed that IHBD cells are normally CK
positive and HNF4α negative (Fig. 5K). In contrast, some duct-
like structures/cysts in Foxa3-Cre;Hhexd2,3/− livers contained
both CK-positive cells and HNF4α-positive cells (Fig. 5L).Although there was variability in the severity of cystogenesis in
mutant embryos, mildly affected mutants also displayed a
similarly abnormal hepatic epithelia as severely affected
embryos. Some ‘hybrid’ cells that were both CK positive and
HNF4α positive were detected and many cysts formed in the
absence of a branch of the portal vein, suggesting the normal
mechanism of BEC induction is not properly functioning in this
mutant (Fig. 5M). In mutants, hepatocytes remained small and
tightly clustered, suggesting a failure to differentiate normally.
Therefore, we conclude that the absence of Hhex in the Foxa3-
Cre;Hhexd2,3/− liver primordium results in abnormal hepato-
blast differentiation and severely abnormal hepatic architecture
by late embryogenesis, most likely due to the loss of HNF4α
and HNF6 expression in the early embryonic liver.
Hhex is required for proper development of the intrahepatic
bile ducts
To determine if Hhex has an essential role in liver
development during late embryogenesis, we used Alfp-Cre
transgenic mice (Zhang et al., 2005; Krupczak-Hollis et al.,
2004; Parviz et al., 2003). Previous studies have shown that
Alfp-Cre provides deletion of a floxed allele in the liver by
E15 (Krupczak-Hollis et al., 2004; Parviz et al., 2003). We
generated Alfp-Cre;Hhexd2,3/− (conditional null) mice by
crossing our Hhexflox mice to Alfp-Cre;Hhex+/− mice.
To assess the extent of deletion of Hhex in Alfp-Cre;
Hhexd2,3/− livers, we performed Hhex immunohistochemistry.
In controls at E18.5, Hhex was detected in the liver in hepatocytes,
IHBD, and endothelial cells (Fig. 6A). In Alfp-Cre;Hhexd2,3/−
embryos, Hhex was absent in hepatocytes and biliary cells as
expected (Fig. 6B). Deletion of Hhex in the Alfp-Cre;Hhexd2,3/−
liver was also confirmed by real-time RT-PCR (data not shown).
We examined Alfp-Cre;Hhexd2,3/− livers at E18.5 for
abnormal epithelial morphology. Hematoxylin and eosin
staining showed that portal vein branches in mutants were
surrounded by abnormal duct-like structures/cysts (compare
Fig. 6C with Fig. 6D). Staining with the biliary CK antibody
showed that control portal tracts had a normal pattern of a few
scattered CK-positive cells around the portal vein, with one or
two IHBD precursors (Fig. 6E). However, portal tracts in Alfp-
Cre;Hhexd2,3/− livers were often surrounded by many irregular
biliary duct-like structures/cysts (Fig. 6F). HNF1β immunos-
taining of Alfp-Cre;Hhexd2,3/− livers showed that, in severely
affected mutants, this transcription factor was absent in many
cystic biliary epithelial cells (compare Fig. 6G with Fig. 6H).
Also, hybrid cells (both HNF4α and CK positive) were present
in duct-like structures/cysts surrounding portal veins, and these
hybrid cells were not detected in control IHBD (compare Fig. 6I
with Fig. 6J). Finally, in mutants, many of the cysts present
throughout the parenchymal tissue appeared to form in the
absence of a branch of the portal vein (compare Fig. 6K with
Fig. 6L). The irregular duct-like structures/cysts in Alfp-Cre;
Hhexd2,3/− mutants is characteristic of a ductal plate malforma-
tion (DPM) and this suggests that Hhex plays a role in ductal
plate remodeling and/or in the regulation of periportal cell
differentiation.
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progressive form of polycystic liver disease
In contrast to deletion of Hhex in the hepatic diverticulum in
Foxa3-Cre;Hhexd2,3/− embryos, which was embryonic lethal,
deletion of Hhex in the embryonic liver in Alfp-Cre;Hhexd2,3/−
mice was not lethal. Genotyping showed that in crosses between
Hhexflox/+ mice and Alfp-Cre;Hhex+/− mice, 14 out of 89 pups
were Alfp-Cre;Hhexd2,3/− (16% actual, 12.5% expected).
We examined livers in mice from 8 weeks to 73 weeks of age.
Hepatic cysts were visible on the surface of the liver in 24 out of
26 Alfp-Cre;Hhexd2,3/− mice, while none of the control mice
examined had cysts (Figs. 7A–F). Analysis of four 8-week-old
mice revealed that the most severely affected liver had N50
visible hepatic cysts. The three other Alfp-Cre;Hhexd2,3/− livers
that were examined at this age had N29, N25, and N16 visible
hepatic cysts. Many cysts were multiloculated and almost all
cysts contained a clear fluid (Fig. 7B). Hepatic cysts visible at the
liver surface ranged in size from approximately 0.5 mm to 8 mm
in diameter. The largest cyst identified was approximately
8 mm×8 mm×15 mm (Fig. 7D). Cysts were seen in all lobes of
the liver and were common near the ventral midline and
periphery (Fig. 7F). There was some variability in the severity of
the liver phenotypes among the different age groups. However,
the severity of cystogenesis tended to be worse in older mutant
animals. Most mutant mice examined around 1 year of age and
older had severe polycystic liver disease (Figs. 7G, H).
In human polycystic liver disease, hepatic cysts arise from
BEC and are associated with defects in the development of
IHBD. Histological analysis of adult Alfp-Cre;Hhexd2,3/− liversFig. 5. The Foxa3-Cre;Hhexd2,3/− mutant liver is severely abnormal by late
embryogenesis. (A–D) Hematoxylin and eosin (H&E) staining at E16.5 (A, B)
and E18.5 (C, D). (A) Control ventral liver periphery. (B) Foxa3-Cre;Hhexd2,3/−
mutant ventral liver periphery showing loss of cohesive structure and trapping of
blood cells (arrows). (C) A large branch of the portal vein is shown with an
IHBD (arrowhead) in the control liver. (D) Severe Foxa3-Cre;Hhexd2,3/−mutant
liver phenotype. The mutant liver was severely cystic, and hepatic architecture
appeared grossly abnormal. (E, F) CK immunostaining at E18.5. (E) Biliary
epithelia of the IHBD (arrowhead) and the gall bladder (arrow) are strongly
positive for CK. (F) Severe Foxa3-Cre;Hhexd2,3/− mutant liver phenotype.
Mutant livers had duct-like structures/cysts lined by CK-positive cells
(asterisks), CK-negative cells (arrowheads), and both CK-positive and CK-
negative cells (arrows). The large biliary cyst on the right (double arrowhead) is
probably derived from cystic duct epithelium. V=presumptive junction of
inferior vena cava and main portal vein. Ventral is to the right in panels E and F.
(G, H) Hhex immunostaining at E18.5. (G) Hhex is expressed in biliary cells of
IHBD (arrowheads) and in hepatocytes in controls. me=periportal mesench-
yme. (H) Hhex is absent in cystic biliary epithelia (arrows) and in hepatocytes in
the mutant. (I, J) HNF1β immunostaining at E18.5. (I) In the control, HNF1β is
expressed in biliary cells of intrahepatic bile ducts (arrowhead). (J) In the
mutant, HNF1β is absent or weakly expressed in most cystic cells (arrows).
(K–M) HNF4α (red)+CK (green) dual immunofluorescence at E18.5. (K)
In the control, IHBD cells (outlined) are CK positive and HNF4α negative.
(L, M) Foxa3-Cre;Hhexd2,3/− mutants. (L) Severe mutant phenotype. A
large duct-like structure/cyst (outlined) containing both CK-positive cells
(arrowhead) and HNF4α-positive cells (arrow). (M) Biliary cysts (arrow) are
detected in the absence of the portal vein, and some hybrid cells (both
HNF4α positive and CK positive) were also detected in cysts (arrowhead).
Hepatocytes (HNF4α positive) remain small and tightly clustered (compare
to control in panel K). Scale bar=50 μm.
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mally, only one or two IHBD form near each branch of the
portal vein (Fig. 8A). In Alfp-Cre;Hhexd2,3/− livers, portal veins
were surrounded by multiple cysts and irregular duct-like
structures (Fig. 8B), most lined by a single layer of cuboidal or
flattened epithelium (data not shown), suggesting that the cysts
were of biliary cell origin. In addition, no red blood cells were
detected in cysts examined by H&E staining at 8 weeks of age
(data not shown), confirming that these cysts were not vascular
structures.To verify that the cysts found in Alfp-Cre;Hhexd2,3/− livers
were biliary in origin, we performed immunohistochemistry
using the biliary CK antibody. In control livers, CK staining is
confined to cells lining the IHBD (Fig. 8C) and is absent in
periportal hepatocytes. In Alfp-Cre;Hhexd2,3/− livers, portal
veins were often surrounded by large CK-positive biliary cysts
and many smaller CK-positive cysts, ducts, or ductal plate
remnants (Fig. 8D). The abnormal expression of biliary-specific
CK was also detected in some periportal cells. To examine these
cysts further, we performed a histological stain for collagen.
Bile ducts and portal veins are normally incorporated into a
collagen-rich extracellular matrix. A relatively thin layer of
collagen-positive periportal mesenchyme surrounded portal
veins and IHBD in controls (Fig. 8E). In severely affected
Alfp-Cre;Hhexd2,3/− livers, portal tracts and cysts were sur-
rounded by an extensive layer of collagen deposition (Fig. 8F).
From these results, we conclude that hepatic cysts in Alfp-Cre;
Hhexd2,3/− mice are lined by biliary cells and are a result of
abnormal morphogenesis of IHBD.
In polycystic disease, cystic epithelial cells have an increased
rate of proliferation when compared to normal epithelia
(Gregoire et al., 1987; reviewed in Alvaro et al., 2006). In
fact, normal biliary cells of IHBD have been described as
postmitotic (Fabris et al., 2000). We examined control bile ducts
and Alfp-Cre;Hhexd2,3/− cystic epithelia by dual-label immuno-
fluorescence for the expression of the proliferation marker Ki-67
and biliary CK. In control mice, we found that only 2.3%
(n=395) of CK-positive cells were also positive for Ki-67 (Figs.
8G–I). However, cystic biliary epithelia in mutant mice had a
greater than four-fold higher rate of proliferation (9.6%, n=707;
Figs. 8J–L) than normal biliary cells and this was a statistically
significant difference (Student's T-test: Pb0.05). Therefore,
abnormal proliferation of cystic biliary epithelial cells in Alfp-
Cre;Hhexd2,3/− mutants may contribute to the progression of
cystogenesis in these mice.
Discussion
Hhex has previously been shown to be essential in formation
of the liver primordium in mouse. In Hhex−/− mutant embryos,Fig. 6. Hhex is required for the proper development of intrahepatic bile ducts.
(A, B) Hhex immunostaining on liver sections at E18.5. (A) In controls, Hhex
was detected in hepatocytes, biliary epithelial cells of the IHBD (outlined), and
endothelial cells (arrowhead). (B) In Alfp-Cre;Hhexd2,3/−mutants, Hhex was not
detected in liver parenchyma or BEC (outlined), but Hhex was detected in
endothelial cells (arrowhead). (C, D) H&E staining. (C) Control portal vein with
IHBD precursor (arrowhead). (D) Mutant portal vein with abnormal duct-like
structures/cysts (asterisks). (E, F) CK immunostaining. (E) In controls, portal
veins were associated with one or two CK-positive IHBD (arrowhead). (F) In
mutants, portal veins were surrounded by many CK-positive cysts and duct-like
structures (asterisks). (G, H) HNF1β immunostaining. (G) In the control,
HNF1β was detected in biliary cells of IHBD (outlined). (H) In Alfp-Cre;
Hhexd2,3/− mutants, some cysts had many cells that were HNF1β negative
(arrowheads). (I–L) HNF4α and CK dual-label immunofluorescence. (I) In
controls, IHBD cells are CK positive and HNF4α negative (arrow). (J) In
mutants, many cystic CK-positive cells were also HNF4α positive (arrowheads).
(K) In controls, parenchymal tissue is composed mainly of HNF4α-positive
hepatocytes. (L) In mutants, cysts (asterisks) with hybrid cells (arrowhead) were
present throughout the liver.
Fig. 7. Deletion of Hhex in the embryonic liver results in polycystic liver disease
in adult mice. (A, B) Ventral views of livers at 12 weeks of age. (A) Control liver
and gall bladder filled with bile (arrow). (B) Alfp-Cre;Hhexd2,3/− mutant liver
and gall bladder filled with bile (arrow). Arrowhead indicates a large hepatic
cyst filled with a clear fluid. (C, D) Ventral views of livers at 28 weeks of age.
(C) Control liver. (D) Numerous cysts are obvious throughout the liver
(arrowhead). Double arrowhead shows an extremely large hepatic cyst. (E, F)
Ventro-caudal views of dissected livers at 37 weeks of age. (E) Control liver. (F)
The Alfp-Cre;Hhexd2,3/− liver has many large, multi-loculated cysts (arrow-
heads) and some discoloration, probably due to fibrosis. (G) A mutant liver at
43 weeks of age with severe cystic disease. (F) Ventro-caudal view of a mutant
liver (fixed) at 73 weeks of age, which is almost completely cystic. st=stomach,
d=duodenum.
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(Keng et al., 2000; Martinez-Barbera et al., 2000). Hhex
appears to be important for early ventral endodermal
proliferation because in Hhex−/− embryos, endodermal cells
of the ventral–lateral foregut have a reduced rate of
proliferation (Bort et al., 2004). As well, cells of the hepatic
diverticulum in Hhex−/− embryos fail to breakdown laminin
and delaminate into the surrounding mesenchyme. These
defects are associated with aberrant interkinetic nuclear
migration and a failure in the conversion of the hepatic
endoderm to a pseudostratified epithelium (Bort et al., 2006).Hhex is also required for budding of the cystic primordium
and ventral pancreas (Bort et al., 2004; Bort et al., 2006). We
have shown here that Hhex is expressed in hepatobiliary
tissue throughout embryogenesis and in the adult. To
overcome the very early arrest in hepatobiliary development
in the Hhex−/− embryos, we have derived Hhex conditional
null mice using the Cre-loxP system, allowing us to address
the roles of Hhex in later stages of liver and biliary
development. We have shown, for the first time, that Hhex is
required for hepatic differentiation and morphogenesis after
liver bud formation. A summary of the differences between the
Hhex−/−, Foxa3-Cre;Hhexd2,3/−, and Alfp-Cre;Hhexd2,3/−
mutant phenotypes is shown in Fig. 9.
Hhex is necessary for the proper morphogenesis of the
extrahepatic biliary tract
Hhex is expressed in the epithelium of the extrahepatic
biliary tract, including the EHBD and gall bladder, from E10.5
through late embryogenesis. Deletion of Hhex in the hepatic
diverticulum of Foxa3-Cre;Hhexd2,3/− mutants resulted in the
absence of the gall bladder and replacement of the EHBD by
duodenum. In some Foxa3-Cre;Hhexd2,3/− mutants, there was
a large ventral midline cystic structure, which is most likely
derived from cystic duct epithelium, rather than gall bladder
epithelium, because we could not identify the gall bladder
primordium at E10.5 by HNF6 immunostaining. In no case
was a well-defined gall bladder ever found in Foxa3-Cre;
Hhexd2,3/− mutants at E18.5. The replacement of the EHBD
by duodenum may result from an arrest in development, or a
change in cell fate. Interestingly, it was recently suggested that
Hhex has an important role in the epithelial transformation of
ventral foregut endoderm cells (Bort et al., 2006). We
speculate that, in the absence of Hhex, most cells in the
caudal hepatic diverticulum that are normally fated to form the
EHBD instead become duodenal cells. This hypothesis is
supported by several lines of evidence. In Hhex−/− mutant
embryos, it has been suggested that cells of the hepatic
diverticulum take on characteristics of duodenal cells at E10.5
because they ectopically express gata4 and shh (Bort et al.,
2006). In addition, the EHBD, duodenum, and pancreas
normally develop from adjacent regions of the foregut
endoderm, and it has previously been shown that this part
of the endoderm retains some plasticity during development
(Fukuda et al., 2006; Sumazaki et al., 2004; Offield et al.,
1996). However, cell lineage analysis will be necessary to
confirm a change in cell fate of hepatic endoderm cells in
Foxa3-Cre;Hhexd2,3/− mutants. The observation of HNF6-
positive epithelial cells at the base of the mutant liver, and in
direct contact with duodenal epithelium, could suggest a
remnant of the proximal EHBD. Therefore, Hhex may
normally function to suppress the duodenal differentiation
program in the cells that give rise to more distal portions of
the EHBD. It is interesting to note that the role of Hhex in
EHBD development appears to be conserved because in a
Hhex morphant in zebrafish the EHBD could not be identified
(Wallace et al., 2001).
Fig. 8. Hhex is required for proper morphogenesis of intrahepatic bile ducts. Histology and immunostaining on liver sections from mice at 28 weeks of age. (A, B)
H&E staining. (A) In controls, portal veins are generally associated with one or two IHBD (arrowheads). (B) In Alfp-Cre;Hhexd2,3./− mutants, portal veins are
surrounded by multiple duct-like structures/cysts (asterisks). (C, D) CK immunohistochemistry. (C) CK expression is normally confined to biliary epithelial cells lining
the IHBD in the periportal region (arrowheads). (D) Asterisks show large CK-positive biliary cysts surrounding a branch of the portal vein in the mutant. Arrowheads
show multiple smaller ducts/cysts in the periportal region. Arrows show an up-regulation of biliary-specific CK in periportal cells. (E, F) Picro-sirius red staining for
collagen. (E) In controls, a relatively thin layer of collagen (red staining) surrounds the IHBD (arrowheads) and portal veins. (F) In mutants, extensive collagen
deposition (arrows) was detected around cysts (asterisks) and portal veins. (G–L) Dual-label immunofluorescence for CK (red) and Ki-67 (green). (G–I) Control
IHBD. (G) CK-positive BEC. (H) In general, BEC are normally Ki-67 negative. (I) Merged image of panels G and H. Scale bar is 10 μm. (J–L) Alfp-Cre;Hhexd2,3/−
cyst epithelia. (J) Cystic epithelia are CK positive. (K) Many cells lining cysts are Ki-67 positive (arrowheads). (L) Merged image of panels J and K. Scale bar is 20 μm.
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hepatoblast differentiation
Our work strongly suggests that Hhex is essential in the
proper differentiation of hepatoblasts. In Foxa3-Cre;Hhexd2,3/−
embryos, HNF4α and HNF6 were absent in hepatoblasts of the
early embryonic liver. Hnf4α has been shown to be essential in
hepatoblast differentiation and the establishment of normal
hepatic parenchymal epithelium (Parviz et al., 2003). Condi-
tional deletion of Hnf4α resulted in some livers that lost their
cohesive structure, had large lesions, and were falling apart.
Recently, HNF4α has been shown to regulate the expression of
multiple proteins required in cell junction assembly andadhesion during liver development (Battle et al., 2006). In
Hnf6−/− mutants, differentiation of hepatoblasts was abnormal
with excessive formation of biliary epithelial cells and cysts
(Clotman et al., 2002). The absence of HNF4α and HNF6 in the
early liver of Foxa3-Cre;Hhexd2,3/− mutants most likely
explains the severe defects in the hepatic epithelium seen later
in development. These defects included a loss of cohesive
structure in the ventral liver periphery, severe cystogenesis, and
the presence of cystic epithelium with both biliary-like (CK
positive) and hepatocyte-like (HNF4α positive) cells. Hnf4α
and Hnf6 are components of a complex genetic network of
liver-enriched transcription factors, and how Hhex fits into this
network remains to be determined. We suggest that Hhex has an
Fig. 9. Summary of the effects of Hhex deletion at different stages of liver development. The stages of liver development are noted across the top with the tissues/cell
types that express Hhex noted in green boxes. The consequences of Hhex deletion as well as the specific Hhex-deleted mouse strain are noted and summarized in the
red boxes.
365M.P. Hunter et al. / Developmental Biology 308 (2007) 355–367essential role in hepatoblast differentiation in the early
embryonic liver through positive regulation of Hnf4α and
Hnf6 expression. Why Hhex is absolutely essential for HNF4α
and HNF6 expression only in the early hepatoblast is unknown,
but other LETF's, such as Foxa2 (HNF3β) and HNF4α, have
also been shown to function differently in the fetal versus the
adult liver (Sund et al., 2000; Hayhurst et al., 2001).
Interestingly, HNF6 has been shown to regulate the expression
of Hnf4α in the embryonic liver (Briancot et al., 2004). The
regulation of Hnf4α expression is complex with two promoters,
P1 and P2, and their respective transcripts Hnf4α1 and Hnf4α7
(Briancot et al., 2004; Odom et al., 2004). HNF6 activates the
P2 promoter in the embryonic liver, and throughout develop-
ment there is a switch to almost exclusively P1 promoter
activity in mature hepatocytes (Briancot et al., 2004). We have
identified two conserved Hhex consensus binding sites
approximately 15 kb upstream of the Hnf6 transcription start
site (data not shown) suggesting that Hnf6may be a direct target
of Hhex.
Hhex is essential during late embryogenesis for proper
development of intrahepatic bile ducts
Deletion of Hhex in the liver during late embryogenesis in
Alfp-Cre;Hhexd2,3/− mutants resulted in abnormal morphogen-
esis of IHBD. In the mutant livers, portal tracts were surrounded
by biliary cysts and irregular duct-like structures. Further, many
periportal cells lining the cysts lacked HNF1β expression.
Hnf1β has been shown to be essential in normal differentiation
and development of IHBD in mice (Coffinier et al., 2002). Inmutants with a targeted deletion of Hnf1β in the embryonic
liver, the ductal plate was very disorganized with irregular duct-
like structures at E17.5. We believe the absence of HNF1β in
some cystic epithelial cells most likely reflects abnormal
periportal cell differentiation. In support of this, we have
shown that some cystic biliary cells were positive for HNF4α.
These abnormal hybrid cells expressed both hepatoblast/
hepatocyte (HNF4α) and biliary (CK) cell markers and have
previously been described in the Hnf6−/− mutant (Clotman et
al., 2005). HNF6 is a member of the Onecut family of
transcription factors and was shown to be required for IHBD
morphogenesis by regulation of hepatoblast differentiation
(Clotman et al., 2002). The presence of hybrid cells in Alfp-
Cre;Hhexd2,3/− mutants suggests that Hhex is required for
proper differentiation of hepatoblasts into hepatocytes and
biliary cells. Perhaps in the absence of Hhex, some hepatoblasts
arrest their differentiation or certain hepatoblasts/hepatocytes
may abnormally activate biliary cell differentiation.
Additionally, we have detected biliary cysts that were present
throughout the parenchymal tissue (i.e. in the absence of a
branch of the portal vein), which implies the normal mechanism
of biliary cell induction in hepatoblasts adjacent to the
mesenchyme of the portal vein is not functioning in these
mutants. Similar results were seen in the Hnf6−/−;Oc-2−/−
double knockout mice and it was suggested that these Onecut
transcription factors control cell lineage decision by regulating
periportal TGFβ signaling (Clotman et al., 2005). We did not
detect any obvious differences in Hnf6 expression during late
embryogenesis between Alfp-Cre;Hhexd2,3/− mutants and con-
trols by immunohistochemistry (data not shown). Further
366 M.P. Hunter et al. / Developmental Biology 308 (2007) 355–367studies are necessary to determine whether Hhex has a similar
role in biliary cell differentiation as HNF6 by regulating the
expression of components of the TGFβ pathway.
The liver phenotype in our Alfp-Cre;Hhexd2,3/− mice
resembles human polycystic liver disease. The most common
forms of this disease involve a slow, progressive cystogenesis
that can result in organ failure (reviewed in Tahvanainen et al.,
2005). In most cases, the disease usually presents in the fourth
or fifth decade of life, and liver function tests are often normal
(Arnold and Harrison, 2005). Blood serum levels of total
bilirubin, albumin, alanine transferase, and total protein from
Alfp-Cre;Hhexd2,3/− mice at 2 months of age were normal, but
alkaline phosphatase was increased two-fold in severely
affected mutants (data not shown). Polycystic liver disease is
also associated with abnormal proliferation of the cystic
epithelia (reviewed in Alvaro et al., 2006). In concurrence
with this, Alfp-Cre;Hhexd2,3/− mutants have cystic epithelia
with greater than a four-fold increase in proliferation compared
to control biliary cells. Another characteristic abnormality in all
forms of polycystic disease of the liver is ductal plate
malformation (DPM), which is defined as an arrest in embryonic
morphogenesis of the ductal plate (reviewed by Desmet, 2004).
Our findings of DPM in Alfp-Cre;Hhexd2,3/− mutants indicate a
failure in remodeling of the ductal plate and suggest Hhex may
have a role in this process during embryogenesis.
The differences seen in the severity of the liver phenotypes
between the Foxa3-Cre;Hhexd2,3/− mutants and the Alfp-Cre;
Hhexd2,3/− mutants can be explained by the difference in the
timing of Hhex deletion (summarized in Fig. 9). In Foxa3-Cre;
Hhexd2,3/− mutants, deletion of Hhex appeared to be complete
in the hepatobiliary primordia by E10.5, and this resulted in an
absence of HNF4α and HNF6 expression in the liver at E13.5.
Whereas in Alfp-Cre;Hhexd2,3/− mutants, deletion of Hhex was
restricted to endodermal cells of the liver and did not appear
to be complete in most mutants until late embryogenesis
with no affect on HNF4α or HNF6 expression in the early
liver. Our findings regarding the timing of deletion of a
floxed allele using these Cre transgenics are similar to
previous studies (Parviz et al., 2003; Lee et al., 2005a,
2005b). The difference between the Hhex−/− mutant and the
Foxa3-Cre;Hhexd2,3/− conditional mutant is probably due to
strain-specific differences between these mice and/or perdur-
ance of Hhex protein in the conditional mutant in early
hepatoblasts migrating from the hepatic diverticulum to form
the liver bud.
It is interesting to note here thatHhex has been shown to play
a crucial role in several cell-lineage differentiation pathways
including hematopoiesis, lymphopoiesis, cardiogenesis, and
vascular smooth muscle cell differentiation (Kubo et al., 2005;
Bogue et al., 2003; Foley and Mercola, 2005; Oyama et al.,
2004). Our results suggest that Hhex has a similar role in
regulating hepatoblast differentiation into hepatocytes and
biliary cells. In support of this hypothesis, liver regeneration
studies in rat have shown that Hhex expression is up-regulated
after partial hepatectomy (Tanaka et al., 1999). We are currently
searching for Hhex target genes involved in these cell fate
decisions.Conclusions
We have shown for the first time that Hhex has distinct
functions during different stages of liver and biliary tract
development. Our work has demonstrated essential roles for
Hhex in hepatoblast differentiation and morphogenesis of the
bile ducts. Future studies on the Hhex gene in hepatocyte and
biliary cell differentiation should lead to novel insights into
hepatobiliary disorders in humans.
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